"Intermountain Cancer Center St George is located in St. George, UT and is part of a system of 22 hospitals and about 180 medical clinics operated by Intermountain Healthcare."

During the past decade, Dixie Medical Center Regional Cancer Center conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 39 clinical trials were completed, i.e. on average, 95.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 23 clinical trials were completed. i.e. 383.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dixie Medical Center Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "Radiation Therapy Oncology Group" with 9 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dixie Medical Center Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Dixie Medical Center Regional Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Cervical Adenocarcinoma" (5 trials), "Stage IIIA Breast Cancer" (5 trials) and "Adult Glioblastoma" (4 trials). Many other conditions were trialed in "Dixie Medical Center Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Dixie Medical Center Regional Cancer Center" are "Drug" (60 trials), "Other" (54 trials), "Radiation" (22 trials), "Biological" (20 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (23 trials), "Questionnaire Administration" (16 trials), "Paclitaxel" (13 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Dixie Medical Center Regional Cancer Center" are 52 trials for "All" genders, 23 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Dixie Medical Center Regional Cancer Center". undefined are not yet recruiting, 7 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Dixie Medical Center Regional Cancer Center, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Dixie Medical Center Regional Cancer Center, 2 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".